Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
Plaque Psoriasis Has a New Treatment
The US Food and Drug Administration (FDA) has approved a new treatment for moderate to severe plaque psoriasis.
Experimental Treatment for Psoriasis Shows Promise
A promising new drug to help psoriasis patients control their itchy, frustrating outbreaks may soon be on the way.
FDA Approves New Psoriasis Rx
The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
This Skin Condition Is Expensive
Like other chronic diseases, psoriasis can cost patients an arm and a leg. And as treatments improve and awareness increases, those treatment costs could be money well spent.
Psoriasis May Increase High Blood Pressure Risk
Psoriasis is an inflammatory skin condition, but it may be more than skin-deep. It may also raise high blood pressure risk.
FDA Approves Rx for Plaque Psoriasis
More than 125 million people across the globe have psoriasis. The US Food and Drug Administration (FDA) approved a medicine Tuesday that may be able to treat them.
Rx Shows Promise for Treating Psoriasis
Psoriasis can be a painful and uncomfortable disease. A few products currently on the market may ease symptoms of this skin condition. Now, a new medication is showing promise in clinical trials.
Psoriasis Risk Tied to High Blood Pressure in Women
The health of your heart and that of your skin may not seem that connected, but the authors of a new study suggest that for some women, the two may be intertwined.
Anti-Inflammatory Rx May Ease Psoriatic Arthritis
About 15 percent of psoriasis patients get arthritic inflammation that may cause joint pain, according to the American College of Rheumatology. A new therapy, however, may bring some relief.